French Court Dismisses Genoway's Lawsuit against Cellectis | GenomeWeb

NEW YORK (GenomeWeb News) – French genome engineering company Cellectis said last week that the Paris Tribunal de Grande Instance has dismissed a lawsuit filed against it by Genoway in January.

The third chamber of the Tribunal de Grande Instance returned a verdict stating, among other things, that a contract between Cellectis and Genoway was terminated on December 30, 2008; that the under-license products detained by Genoway must be destroyed; and that an audit of Genoway's accounts is to be resumed in order for Genoway to pay sums owed to Cellectis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.